UK markets closed
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • FTSE 250

    23,658.94
    +26.10 (+0.11%)
     
  • AIM

    1,275.74
    +3.60 (+0.28%)
     
  • GBP/EUR

    1.1711
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.43%)
     
  • BTC-GBP

    34,945.94
    -603.77 (-1.70%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • DOW

    34,584.88
    -166.44 (-0.48%)
     
  • CRUDE OIL

    71.96
    -0.65 (-0.90%)
     
  • GOLD FUTURES

    1,753.90
    -2.80 (-0.16%)
     
  • NIKKEI 225

    30,500.05
    +176.71 (+0.58%)
     
  • HANG SENG

    24,920.76
    +252.91 (+1.03%)
     
  • DAX

    15,490.17
    -161.58 (-1.03%)
     
  • CAC 40

    6,570.19
    -52.40 (-0.79%)
     

Global Pen Needles Market to Reach $2.2 Billion by 2027

·27-min read

Abstract: - Global Pen Needles Market to Reach $2. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Pen Needles estimated at US$1. 2 Billion in the year 2020, is projected to reach a revised size of US$2.

New York, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pen Needles Industry" - https://www.reportlinker.com/p06032471/?utm_source=GNW
2 Billion by 2027, growing at aCAGR of 9.4% over the period 2020-2027. Standard Pen Needles, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Safety Pen Needles segment is readjusted to a revised 11.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $320.9 Million, While China is Forecast to Grow at 12.4% CAGR
- The Pen Needles market in the U.S. is estimated at US$320.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$462.2 Million by the year 2027 trailing a CAGR of 12.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

- Select Competitors (Total 36 Featured) -

  • Allison Medical

  • Artsana S.p.a.

  • B. Braun Melsungen AG

  • Becton

  • Dickinson and Company

  • HTL-STREFA S.A.

  • Novo Nordisk A/S

  • Owen Mumford

  • Terumo Corporation

  • UltiMed, Inc.

  • Ypsomed Holding AG




Read the full report: https://www.reportlinker.com/p06032471/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Pen Needles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Pen Needles by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Standard Pen
Needles by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Standard Pen Needles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Standard Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Safety Pen Needles
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Safety Pen Needles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Safety Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Insulin by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Insulin by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Insulin by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for GLP-1 by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for GLP-1 by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for GLP-1 by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Growth Hormone
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Growth Hormone Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Growth Hormone Therapy
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other Therapies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Other Therapies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other Therapies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 22: USA Current & Future Analysis for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 23: USA Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: USA 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1, Growth
Hormone Therapy and Other Therapies for the Years 2012, 2020 &
2027

CANADA
Table 28: Canada Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: Canada Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: Canada 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 31: Canada Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: Japan Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: Japan 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 37: Japan Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: China Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: China 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 43: China Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

EUROPE
Table 46: Europe Current & Future Analysis for Pen Needles by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Pen Needles by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: France Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: France 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 58: France Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: Germany Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: Germany 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 64: Germany Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Pen Needles by
Therapy - Percentage Breakdown of Value Sales for Insulin,
GLP-1, Growth Hormone Therapy and Other Therapies for the Years
2012, 2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Italy Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: Italy 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 70: Italy Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: UK Historic Review for Pen Needles by Type - Standard
Pen Needles and Safety Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 75: UK 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 76: UK Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1, Growth
Hormone Therapy and Other Therapies for the Years 2012, 2020 &
2027

SPAIN
Table 79: Spain Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: Spain Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 81: Spain 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 82: Spain Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Spain Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 84: Spain 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

RUSSIA
Table 85: Russia Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Russia Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: Russia 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 88: Russia Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Russia Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 90: Russia 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for Pen
Needles by Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Rest of Europe Historic Review for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 93: Rest of Europe 15-Year Perspective for Pen Needles by
Type - Percentage Breakdown of Value Sales for Standard Pen
Needles and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 94: Rest of Europe Current & Future Analysis for Pen
Needles by Therapy - Insulin, GLP-1, Growth Hormone Therapy and
Other Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Rest of Europe Historic Review for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 96: Rest of Europe 15-Year Perspective for Pen Needles by
Therapy - Percentage Breakdown of Value Sales for Insulin,
GLP-1, Growth Hormone Therapy and Other Therapies for the Years
2012, 2020 & 2027

ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Pen
Needles by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 98: Asia-Pacific Historic Review for Pen Needles by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Asia-Pacific 15-Year Perspective for Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2020 & 2027

Table 100: Asia-Pacific Current & Future Analysis for Pen
Needles by Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 101: Asia-Pacific Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 102: Asia-Pacific 15-Year Perspective for Pen Needles by
Type - Percentage Breakdown of Value Sales for Standard Pen
Needles and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for Pen
Needles by Therapy - Insulin, GLP-1, Growth Hormone Therapy and
Other Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for Pen Needles by
Therapy - Percentage Breakdown of Value Sales for Insulin,
GLP-1, Growth Hormone Therapy and Other Therapies for the Years
2012, 2020 & 2027

AUSTRALIA
Table 106: Australia Current & Future Analysis for Pen Needles
by Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Australia Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 108: Australia 15-Year Perspective for Pen Needles by
Type - Percentage Breakdown of Value Sales for Standard Pen
Needles and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 109: Australia Current & Future Analysis for Pen Needles
by Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: Australia Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: Australia 15-Year Perspective for Pen Needles by
Therapy - Percentage Breakdown of Value Sales for Insulin,
GLP-1, Growth Hormone Therapy and Other Therapies for the Years
2012, 2020 & 2027

INDIA
Table 112: India Current & Future Analysis for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: India Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: India 15-Year Perspective for Pen Needles by Type -
Percentage Breakdown of Value Sales for Standard Pen Needles
and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 115: India Current & Future Analysis for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 116: India Historic Review for Pen Needles by Therapy -
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 117: India 15-Year Perspective for Pen Needles by Therapy -
Percentage Breakdown of Value Sales for Insulin, GLP-1,
Growth Hormone Therapy and Other Therapies for the Years 2012,
2020 & 2027

SOUTH KOREA
Table 118: South Korea Current & Future Analysis for Pen
Needles by Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: South Korea Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: South Korea 15-Year Perspective for Pen Needles by
Type - Percentage Breakdown of Value Sales for Standard Pen
Needles and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 121: South Korea Current & Future Analysis for Pen
Needles by Therapy - Insulin, GLP-1, Growth Hormone Therapy and
Other Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 122: South Korea Historic Review for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 123: South Korea 15-Year Perspective for Pen Needles by
Therapy - Percentage Breakdown of Value Sales for Insulin,
GLP-1, Growth Hormone Therapy and Other Therapies for the Years
2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Current & Future Analysis for
Pen Needles by Type - Standard Pen Needles and Safety Pen
Needles - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 125: Rest of Asia-Pacific Historic Review for Pen Needles
by Type - Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 126: Rest of Asia-Pacific 15-Year Perspective for Pen
Needles by Type - Percentage Breakdown of Value Sales for
Standard Pen Needles and Safety Pen Needles for the Years 2012,
2020 & 2027

Table 127: Rest of Asia-Pacific Current & Future Analysis for
Pen Needles by Therapy - Insulin, GLP-1, Growth Hormone Therapy
and Other Therapies - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 128: Rest of Asia-Pacific Historic Review for Pen Needles
by Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 129: Rest of Asia-Pacific 15-Year Perspective for Pen
Needles by Therapy - Percentage Breakdown of Value Sales for
Insulin, GLP-1, Growth Hormone Therapy and Other Therapies for
the Years 2012, 2020 & 2027

LATIN AMERICA
Table 130: Latin America Current & Future Analysis for Pen
Needles by Geographic Region - Argentina, Brazil, Mexico and
Rest of Latin America Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 131: Latin America Historic Review for Pen Needles by
Geographic Region - Argentina, Brazil, Mexico and Rest of Latin
America Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 132: Latin America 15-Year Perspective for Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
Argentina, Brazil, Mexico and Rest of Latin America Markets for
Years 2012, 2020 & 2027

Table 133: Latin America Current & Future Analysis for Pen
Needles by Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 134: Latin America Historic Review for Pen Needles by
Type - Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 135: Latin America 15-Year Perspective for Pen Needles by
Type - Percentage Breakdown of Value Sales for Standard Pen
Needles and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 136: Latin America Current & Future Analysis for Pen
Needles by Therapy - Insulin, GLP-1, Growth Hormone Therapy and
Other Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 137: Latin America Historic Review for Pen Needles by
Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 138: Latin America 15-Year Perspective for Pen Needles by
Therapy - Percentage Breakdown of Value Sales for Insulin,
GLP-1, Growth Hormone Therapy and Other Therapies for the Years
2012, 2020 & 2027

ARGENTINA
Table 139: Argentina Current & Future Analysis for Pen Needles
by Type - Standard Pen Needles and Safety Pen Needles -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 140: Argentina Historic Review for Pen Needles by Type -
Standard Pen Needles and Safety Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 141: Argentina 15-Year Perspective for Pen Needles by
Type - Percentage Breakdown of Value Sales for Standard Pen
Needles and Safety Pen Needles for the Years 2012, 2020 & 2027

Table 142: Argentina Current & Future Analysis for Pen Needles
by Therapy - Insulin, GLP-1, Growth Hormone Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 143: Argentina Historic Review for Pen Needles by Therapy -

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032471/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting